RL
Richard Law
#110 out of 1697 analysts
Goldman Sachs
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
89.42%
Gain -6.2%
Monthly
1.43%
Yearly
18.54%
Drawdown
51.16%
$205,752.14
Equity
Holdings
$205,492.76
Cash
$259.38
Investment
$151,939.35
$105,492.76
Profit -$13,609.66
Realized
$51,939.35
Unrealized
$53,553.41
Dividends
$0
$259.38
Cash
Deposits
$100,259.38
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-6.2%
Profit
-$13,609.66
Win %
100%
This Week
Compared To Last Week
Gain
6.12%
Profit
$11,870.4
Win %
100%
This Month
Compared to last month
Gain
34.28%
Profit
$52,523.02
Win %
100%
This Year
Compared to last year
Gain
29.35%
Profit
$46,689.62
Win %
57%
No Data
COAG Hemab Therapeutics Holdings, Inc.
-6.21%
-$13,609.66 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 142 | Longs Won 58/125 46% | Profit Factor 1.53 |
| Profitability | Shorts Won 9/17 52% | Standard Deviation $5,828.77 |
| Average Win $4,556.37 | Best Trade (Jul 29) $29,105.82 | Sharpe Ratio -65.92 |
| Average Loss -$2,663.79 | Worst Trade (Nov 14) -$22,170.14 | Z-Score -3.09 (100%) |
| Commissions $0 | Avg. Trade Length 2m 4w 1d | Expectancy $742.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | 0.03% | 0.21% | 1.08% | 4.23% | 13.81% | 39.27% |
| Consecutive Losing Trades | 77 | 70 | 62 | 54 | 46 | 39 | 31 | 23 | 15 | 8 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
